| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.033 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0081 | 0.9 |